Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-03-28
Pages: 162 Pages
Report ld: 4669929
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemostats Market Size(US$)
CAGR 2025-2031
5.9%
Market Size,2031
USD 4,570
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,240 million
Market Forecast in 2031(Value)
US$ 4,570 million
CAGR
5.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Hemostats, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostats.
The Hemostats market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemostats market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostats manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Segment by Type
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Segment by Application
Prehospital Treatment
Hospital Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hemostats in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemostats sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Hemostats Product Introduction
1.2 Market by Type
1.2.1 Global Hemostats Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Thrombin-Based Hemostats
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Combination Hemostats
1.2.5 Gelatin Based Hemostats
1.2.6 Collagen Based Hemostats
1.3 Market by Application
1.3.1 Global Hemostats Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Prehospital Treatment
1.3.3 Hospital Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemostats Market Size Estimates and Forecasts
2.1.1 Global Hemostats Revenue 2020-2031
2.1.2 Global Hemostats Sales 2020-2031
2.2 Hemostats Market Size by Region: 2024 Versus 2031
2.3 Hemostats Sales by Region (2020-2031)
2.3.1 Global Hemostats Sales by Region: 2020-2025
2.3.2 Global Hemostats Sales Forecast by Region (2026-2031)
2.3.3 Global Hemostats Sales Market Share by Region (2020-2031)
2.4 Hemostats Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Hemostats Revenue by Region: 2020-2025
2.4.2 Global Hemostats Revenue Forecast by Region (2026-2031)
2.4.3 Global Hemostats Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Hemostats Sales by Type (2020-2031)
3.1.1.1 Global Hemostats Sales Volume by Type (2020-2031)
3.1.1.2 Global Hemostats Sales Market Share by Type (2020-2031)
3.1.2 Global Hemostats Revenue by Type (2020-2031)
3.1.2.1 Global Hemostats Revenue by Type (2020-2031)
3.1.2.2 Global Hemostats Revenue Market Share by Type (2020-2031)
3.1.3 Hemostats Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Hemostats Sales by Application (2020-2031)
3.2.1.1 Global Hemostats Sales Volume by Application (2020-2031)
3.2.1.2 Global Hemostats Sales Market Share by Application (2020-2031)
3.2.2 Global Hemostats Revenue by Application (2020-2031)
3.2.2.1 Global Hemostats Revenue by Application (2020-2031)
3.2.2.2 Global Hemostats Revenue Market Share by Application (2020-2031)
3.2.3 Hemostats Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Thrombin-Based Hemostats of Hemostats Revenue Market Share by Application
3.3.2 Oxidized Regenerated Cellulose Based Hemostats of Hemostats Revenue Market Share by Application
3.3.3 Combination Hemostats of Hemostats Revenue Market Share by Application
3.3.4 Gelatin Based Hemostats of Hemostats Revenue Market Share by Application
3.3.5 Collagen Based Hemostats of Hemostats Revenue Market Share by Application
4 Global Hemostats by Manufacturers
4.1 Global Top Hemostats Manufacturers by Sales (2020-2025)
4.1.1 Global Hemostats Sales by Manufacturer (2020-2025)
4.1.2 Global Hemostats Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Hemostats Manufacturers by Revenue (2020-2025)
4.2.1 Global Hemostats Revenue by Manufacturer (2020-2025)
4.2.2 Global Hemostats Revenue Share by Manufacturer (2020-2025)
4.3 Global Hemostats Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Hemostats Manufacturers Covered: Ranking by Revenue
4.4.2 Global Hemostats Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Hemostats Manufacturing Base Distribution, Product Type
4.5.1 Hemostats Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Hemostats Market
4.5.3 Manufacturers Hemostats Product Type and Application
4.5.4 Thrombin-Based Hemostats Market Sales of Hemostats by Manufacturer
4.5.5 Oxidized Regenerated Cellulose Based Hemostats Market Sales of Hemostats by Manufacturer
4.5.6 Combination Hemostats Market Sales of Hemostats by Manufacturer
4.5.7 Gelatin Based Hemostats Market Sales of Hemostats by Manufacturer
4.5.8 Collagen Based Hemostats Market Sales of Hemostats by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Ethicon
5.1.1 Ethicon Company Information
5.1.2 Ethicon Description, Business Overview
5.1.3 Ethicon Hemostats Products Offered
5.1.4 Ethicon Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Ethicon Hemostats Sales by Product in 2024
5.1.6 Ethicon Hemostats Sales by Application in 2024
5.1.7 Ethicon Hemostats Sales by Geographic Area in 2024
5.1.8 Ethicon Recent Developments
5.2 Pfizer
5.2.1 Pfizer Company Information
5.2.2 Pfizer Description, Business Overview
5.2.3 Pfizer Hemostats Products Offered
5.2.4 Pfizer Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Pfizer Hemostats Sales by Product in 2024
5.2.6 Pfizer Hemostats Sales by Application in 2024
5.2.7 Pfizer Hemostats Sales by Geographic Area in 2024
5.2.8 Pfizer Recent Developments
5.3 Baxter International Inc.
5.3.1 Baxter International Inc. Company Information
5.3.2 Baxter International Inc. Description, Business Overview
5.3.3 Baxter International Inc. Hemostats Products Offered
5.3.4 Baxter International Inc. Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Baxter International Inc. Hemostats Sales by Product in 2024
5.3.6 Baxter International Inc. Hemostats Sales by Application in 2024
5.3.7 Baxter International Inc. Hemostats Sales by Geographic Area in 2024
5.3.8 Baxter International Inc. Recent Developments
5.4 C. R. Bard
5.4.1 C. R. Bard Company Information
5.4.2 C. R. Bard Description, Business Overview
5.4.3 C. R. Bard Hemostats Products Offered
5.4.4 C. R. Bard Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.4.5 C. R. Bard Hemostats Sales by Product in 2024
5.4.6 C. R. Bard Hemostats Sales by Application in 2024
5.4.7 C. R. Bard Hemostats Sales by Geographic Area in 2024
5.4.8 C. R. Bard Recent Developments
5.5 The Medicines Company
5.5.1 The Medicines Company Company Information
5.5.2 The Medicines Company Description, Business Overview
5.5.3 The Medicines Company Hemostats Products Offered
5.5.4 The Medicines Company Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.5.5 The Medicines Company Hemostats Sales by Product in 2024
5.5.6 The Medicines Company Hemostats Sales by Application in 2024
5.5.7 The Medicines Company Hemostats Sales by Geographic Area in 2024
5.5.8 The Medicines Company Recent Developments
5.6 Anika Therapeutics
5.6.1 Anika Therapeutics Company Information
5.6.2 Anika Therapeutics Description, Business Overview
5.6.3 Anika Therapeutics Hemostats Products Offered
5.6.4 Anika Therapeutics Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Anika Therapeutics Hemostats Sales by Product in 2024
5.6.6 Anika Therapeutics Hemostats Sales by Application in 2024
5.6.7 Anika Therapeutics Hemostats Sales by Geographic Area in 2024
5.6.8 Anika Therapeutics Recent Developments
5.7 Advanced Medical Solutions
5.7.1 Advanced Medical Solutions Company Information
5.7.2 Advanced Medical Solutions Description, Business Overview
5.7.3 Advanced Medical Solutions Hemostats Products Offered
5.7.4 Advanced Medical Solutions Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Advanced Medical Solutions Hemostats Sales by Product in 2024
5.7.6 Advanced Medical Solutions Hemostats Sales by Application in 2024
5.7.7 Advanced Medical Solutions Hemostats Sales by Geographic Area in 2024
5.7.8 Advanced Medical Solutions Recent Developments
5.8 Integra LifeSciences Corporation
5.8.1 Integra LifeSciences Corporation Company Information
5.8.2 Integra LifeSciences Corporation Description, Business Overview
5.8.3 Integra LifeSciences Corporation Hemostats Products Offered
5.8.4 Integra LifeSciences Corporation Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Integra LifeSciences Corporation Hemostats Sales by Product in 2024
5.8.6 Integra LifeSciences Corporation Hemostats Sales by Application in 2024
5.8.7 Integra LifeSciences Corporation Hemostats Sales by Geographic Area in 2024
5.8.8 Integra LifeSciences Corporation Recent Developments
5.9 B Braun Melsungen AG
5.9.1 B Braun Melsungen AG Company Information
5.9.2 B Braun Melsungen AG Description, Business Overview
5.9.3 B Braun Melsungen AG Hemostats Products Offered
5.9.4 B Braun Melsungen AG Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.9.5 B Braun Melsungen AG Hemostats Sales by Product in 2024
5.9.6 B Braun Melsungen AG Hemostats Sales by Application in 2024
5.9.7 B Braun Melsungen AG Hemostats Sales by Geographic Area in 2024
5.9.8 B Braun Melsungen AG Recent Developments
5.10 Gelita Medical GmbH
5.10.1 Gelita Medical GmbH Company Information
5.10.2 Gelita Medical GmbH Description, Business Overview
5.10.3 Gelita Medical GmbH Hemostats Products Offered
5.10.4 Gelita Medical GmbH Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Gelita Medical GmbH Hemostats Sales by Product in 2024
5.10.6 Gelita Medical GmbH Hemostats Sales by Application in 2024
5.10.7 Gelita Medical GmbH Hemostats Sales by Geographic Area in 2024
5.10.8 Gelita Medical GmbH Recent Developments
5.11 Equimedical
5.11.1 Equimedical Company Information
5.11.2 Equimedical Description, Business Overview
5.11.3 Equimedical Hemostats Products Offered
5.11.4 Equimedical Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Equimedical Hemostats Sales by Product in 2024
5.11.6 Equimedical Hemostats Sales by Application in 2024
5.11.7 Equimedical Hemostats Sales by Geographic Area in 2024
5.11.8 Equimedical Recent Developments
5.12 Vascular Solutions
5.12.1 Vascular Solutions Company Information
5.12.2 Vascular Solutions Description, Business Overview
5.12.3 Vascular Solutions Hemostats Products Offered
5.12.4 Vascular Solutions Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Vascular Solutions Hemostats Sales by Product in 2024
5.12.6 Vascular Solutions Hemostats Sales by Application in 2024
5.12.7 Vascular Solutions Hemostats Sales by Geographic Area in 2024
5.12.8 Vascular Solutions Recent Developments
5.13 Marine Polymer Technologies
5.13.1 Marine Polymer Technologies Company Information
5.13.2 Marine Polymer Technologies Description, Business Overview
5.13.3 Marine Polymer Technologies Hemostats Products Offered
5.13.4 Marine Polymer Technologies Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Marine Polymer Technologies Hemostats Sales by Product in 2024
5.13.6 Marine Polymer Technologies Hemostats Sales by Application in 2024
5.13.7 Marine Polymer Technologies Hemostats Sales by Geographic Area in 2024
5.13.8 Marine Polymer Technologies Recent Developments
5.14 Z-Medica, LLC
5.14.1 Z-Medica, LLC Company Information
5.14.2 Z-Medica, LLC Description, Business Overview
5.14.3 Z-Medica, LLC Hemostats Products Offered
5.14.4 Z-Medica, LLC Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Z-Medica, LLC Hemostats Sales by Product in 2024
5.14.6 Z-Medica, LLC Hemostats Sales by Application in 2024
5.14.7 Z-Medica, LLC Hemostats Sales by Geographic Area in 2024
5.14.8 Z-Medica, LLC Recent Developments
5.15 CryoLife
5.15.1 CryoLife Company Information
5.15.2 CryoLife Description, Business Overview
5.15.3 CryoLife Hemostats Products Offered
5.15.4 CryoLife Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.15.5 CryoLife Hemostats Sales by Product in 2024
5.15.6 CryoLife Hemostats Sales by Application in 2024
5.15.7 CryoLife Hemostats Sales by Geographic Area in 2024
5.15.8 CryoLife Recent Developments
5.16 BioCer Entwicklungs-GmbH.
5.16.1 BioCer Entwicklungs-GmbH. Company Information
5.16.2 BioCer Entwicklungs-GmbH. Description, Business Overview
5.16.3 BioCer Entwicklungs-GmbH. Hemostats Products Offered
5.16.4 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.16.5 BioCer Entwicklungs-GmbH. Hemostats Sales by Product in 2024
5.16.6 BioCer Entwicklungs-GmbH. Hemostats Sales by Application in 2024
5.16.7 BioCer Entwicklungs-GmbH. Hemostats Sales by Geographic Area in 2024
5.16.8 BioCer Entwicklungs-GmbH. Recent Developments
5.17 Biom'Up SAS
5.17.1 Biom'Up SAS Company Information
5.17.2 Biom'Up SAS Description, Business Overview
5.17.3 Biom'Up SAS Hemostats Products Offered
5.17.4 Biom'Up SAS Hemostats Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Biom'Up SAS Hemostats Sales by Product in 2024
5.17.6 Biom'Up SAS Hemostats Sales by Application in 2024
5.17.7 Biom'Up SAS Hemostats Sales by Geographic Area in 2024
5.17.8 Biom'Up SAS Recent Developments
6 North America
6.1 North America Hemostats Market Size YoY Growth 2020-2031
6.2 North America Hemostats Market Facts & Figures by Country
6.2.1 North America Hemostats Sales by Country (2020-2031)
6.2.2 North America Hemostats Revenue by Country (2020-2031)
6.3 North America Hemostats Sales by Type (2020-2025)
6.4 North America Hemostats Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Hemostats Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Hemostats Market Facts & Figures by Region
7.2.1 Asia-Pacific Hemostats Sales by Region (2020-2031)
7.2.2 Asia-Pacific Hemostats Revenue by Region (2020-2031)
7.3 Asia-Pacific Hemostats Sales by Type (2020-2025)
7.4 Asia-Pacific Hemostats Sales by Application (2020-2025)
8 Europe
8.1 Europe Hemostats Market Size YoY Growth 2020-2031
8.2 Europe Hemostats Market Facts & Figures by Country
8.2.1 Europe Hemostats Sales by Country (2020-2031)
8.2.2 Europe Hemostats Revenue by Country (2020-2031)
8.3 Europe Hemostats Sales by Type (2020-2025)
8.4 Europe Hemostats Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Hemostats Market Size YoY Growth 2020-2031
9.2 Latin America Hemostats Market Facts & Figures by Country
9.2.1 Latin America Hemostats Sales by Country (2020-2031)
9.2.2 Latin America Hemostats Revenue by Country (2020-2031)
9.3 Latin America Hemostats Sales by Type (2020-2025)
9.4 Latin America Hemostats Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Hemostats Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Hemostats Market Facts & Figures by Country
10.2.1 Middle East and Africa Hemostats Sales by Country (2020-2031)
10.2.2 Middle East and Africa Hemostats Revenue by Country (2020-2031)
10.3 Middle East and Africa Hemostats Sales by Type (2020-2025)
10.4 Middle East and Africa Hemostats Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Hemostats Supply Chain Analysis
11.2 Hemostats Key Raw Materials and Upstream Suppliers
11.3 Hemostats Clients Analysis
11.4 Hemostats Sales Channel and Sales Model Analysis
11.4.1 Hemostats Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Hemostats Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Hemostats Distributors
12 Hemostats Market Dynamics
12.1 Hemostats Industry Trends
12.2 Hemostats Market Drivers
12.3 Hemostats Market Challenges
12.4 Hemostats Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hemostats Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Hemostats Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Hemostats Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Hemostats Sales by Region (2020-2025) & (K Pcs)
Table 5. Global Hemostats Sales Forecast by Region (2026-2031) & (K Pcs)
Table 6. Global Hemostats Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Hemostats Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Hemostats Sales Volume by Type (2020-2025) & (K Pcs)
Table 9. Global Hemostats Sales Volume by Type (2026-2031) & (K Pcs)
Table 10. Global Hemostats Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Hemostats Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Hemostats Sales Volume by Application (2020-2025) & (K Pcs)
Table 13. Global Hemostats Sales Volume by Application (2026-2031) & (K Pcs)
Table 14. Global Hemostats Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Hemostats Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Hemostats Sales by Manufacturer (2020-2025) & (K Pcs)
Table 17. Global Hemostats Sales Share by Manufacturer (2020-2025)
Table 18. Hemostats Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Hemostats Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Hemostats Price (2020-2025) & (USD/Pcs)
Table 21. Ranking of Global Top Hemostats Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Hemostats Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Hemostats by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostats as of 2024)
Table 24. Hemostats Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Hemostats Market
Table 26. Manufacturers Hemostats Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Ethicon Company Information
Table 29. Ethicon Description and Business Overview
Table 30. Ethicon Hemostats Product
Table 31. Ethicon Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 32. Ethicon Sales Proportion of Hemostats by Product in 2024
Table 33. Ethicon Sales Proportion of Hemostats by Application in 2024
Table 34. Ethicon Sales Proportion of Hemostats by Geographic Area in 2024
Table 35. Ethicon Recent Developments
Table 36. Pfizer Company Information
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Hemostats Product
Table 39. Pfizer Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 40. Pfizer Sales Proportion of Hemostats by Product in 2024
Table 41. Pfizer Sales Proportion of Hemostats by Application in 2024
Table 42. Pfizer Sales Proportion of Hemostats by Geographic Area in 2024
Table 43. Pfizer Recent Developments
Table 44. Baxter International Inc. Company Information
Table 45. Baxter International Inc. Description and Business Overview
Table 46. Baxter International Inc. Hemostats Product
Table 47. Baxter International Inc. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 48. Baxter International Inc. Sales Proportion of Hemostats by Product in 2024
Table 49. Baxter International Inc. Sales Proportion of Hemostats by Application in 2024
Table 50. Baxter International Inc. Sales Proportion of Hemostats by Geographic Area in 2024
Table 51. Baxter International Inc. Recent Developments
Table 52. C. R. Bard Company Information
Table 53. C. R. Bard Description and Business Overview
Table 54. C. R. Bard Hemostats Product
Table 55. C. R. Bard Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 56. C. R. Bard Sales Proportion of Hemostats by Product in 2024
Table 57. C. R. Bard Sales Proportion of Hemostats by Application in 2024
Table 58. C. R. Bard Sales Proportion of Hemostats by Geographic Area in 2024
Table 59. C. R. Bard Recent Developments
Table 60. The Medicines Company Company Information
Table 61. The Medicines Company Description and Business Overview
Table 62. The Medicines Company Hemostats Product
Table 63. The Medicines Company Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 64. The Medicines Company Sales Proportion of Hemostats by Product in 2024
Table 65. The Medicines Company Sales Proportion of Hemostats by Application in 2024
Table 66. The Medicines Company Sales Proportion of Hemostats by Geographic Area in 2024
Table 67. The Medicines Company Recent Developments
Table 68. Anika Therapeutics Company Information
Table 69. Anika Therapeutics Description and Business Overview
Table 70. Anika Therapeutics Hemostats Product
Table 71. Anika Therapeutics Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 72. Anika Therapeutics Sales Proportion of Hemostats by Product in 2024
Table 73. Anika Therapeutics Sales Proportion of Hemostats by Application in 2024
Table 74. Anika Therapeutics Sales Proportion of Hemostats by Geographic Area in 2024
Table 75. Anika Therapeutics Recent Developments
Table 76. Advanced Medical Solutions Company Information
Table 77. Advanced Medical Solutions Description and Business Overview
Table 78. Advanced Medical Solutions Hemostats Product
Table 79. Advanced Medical Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Advanced Medical Solutions Sales Proportion of Hemostats by Product in 2024
Table 81. Advanced Medical Solutions Sales Proportion of Hemostats by Application in 2024
Table 82. Advanced Medical Solutions Sales Proportion of Hemostats by Geographic Area in 2024
Table 83. Advanced Medical Solutions Recent Developments
Table 84. Integra LifeSciences Corporation Company Information
Table 85. Integra LifeSciences Corporation Description and Business Overview
Table 86. Integra LifeSciences Corporation Hemostats Product
Table 87. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Integra LifeSciences Corporation Sales Proportion of Hemostats by Product in 2024
Table 89. Integra LifeSciences Corporation Sales Proportion of Hemostats by Application in 2024
Table 90. Integra LifeSciences Corporation Sales Proportion of Hemostats by Geographic Area in 2024
Table 91. Integra LifeSciences Corporation Recent Developments
Table 92. B Braun Melsungen AG Company Information
Table 93. B Braun Melsungen AG Description and Business Overview
Table 94. B Braun Melsungen AG Hemostats Product
Table 95. B Braun Melsungen AG Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. B Braun Melsungen AG Sales Proportion of Hemostats by Product in 2024
Table 97. B Braun Melsungen AG Sales Proportion of Hemostats by Application in 2024
Table 98. B Braun Melsungen AG Sales Proportion of Hemostats by Geographic Area in 2024
Table 99. B Braun Melsungen AG Recent Developments
Table 100. Gelita Medical GmbH Company Information
Table 101. Gelita Medical GmbH Description and Business Overview
Table 102. Gelita Medical GmbH Hemostats Product
Table 103. Gelita Medical GmbH Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Gelita Medical GmbH Sales Proportion of Hemostats by Product in 2024
Table 105. Gelita Medical GmbH Sales Proportion of Hemostats by Application in 2024
Table 106. Gelita Medical GmbH Sales Proportion of Hemostats by Geographic Area in 2024
Table 107. Gelita Medical GmbH Recent Developments
Table 108. Equimedical Company Information
Table 109. Equimedical Description and Business Overview
Table 110. Equimedical Hemostats Product
Table 111. Equimedical Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. Equimedical Sales Proportion of Hemostats by Product in 2024
Table 113. Equimedical Sales Proportion of Hemostats by Application in 2024
Table 114. Equimedical Sales Proportion of Hemostats by Geographic Area in 2024
Table 115. Equimedical Recent Developments
Table 116. Vascular Solutions Company Information
Table 117. Vascular Solutions Description and Business Overview
Table 118. Vascular Solutions Hemostats Product
Table 119. Vascular Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 120. Vascular Solutions Sales Proportion of Hemostats by Product in 2024
Table 121. Vascular Solutions Sales Proportion of Hemostats by Application in 2024
Table 122. Vascular Solutions Sales Proportion of Hemostats by Geographic Area in 2024
Table 123. Vascular Solutions Recent Developments
Table 124. Marine Polymer Technologies Company Information
Table 125. Marine Polymer Technologies Description and Business Overview
Table 126. Marine Polymer Technologies Hemostats Product
Table 127. Marine Polymer Technologies Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Marine Polymer Technologies Sales Proportion of Hemostats by Product in 2024
Table 129. Marine Polymer Technologies Sales Proportion of Hemostats by Application in 2024
Table 130. Marine Polymer Technologies Sales Proportion of Hemostats by Geographic Area in 2024
Table 131. Marine Polymer Technologies Recent Developments
Table 132. Z-Medica, LLC Company Information
Table 133. Z-Medica, LLC Description and Business Overview
Table 134. Z-Medica, LLC Hemostats Product
Table 135. Z-Medica, LLC Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136. Z-Medica, LLC Sales Proportion of Hemostats by Product in 2024
Table 137. Z-Medica, LLC Sales Proportion of Hemostats by Application in 2024
Table 138. Z-Medica, LLC Sales Proportion of Hemostats by Geographic Area in 2024
Table 139. Z-Medica, LLC Recent Developments
Table 140. CryoLife Company Information
Table 141. CryoLife Description and Business Overview
Table 142. CryoLife Hemostats Product
Table 143. CryoLife Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 144. CryoLife Sales Proportion of Hemostats by Product in 2024
Table 145. CryoLife Sales Proportion of Hemostats by Application in 2024
Table 146. CryoLife Sales Proportion of Hemostats by Geographic Area in 2024
Table 147. CryoLife Recent Developments
Table 148. BioCer Entwicklungs-GmbH. Company Information
Table 149. BioCer Entwicklungs-GmbH. Description and Business Overview
Table 150. BioCer Entwicklungs-GmbH. Hemostats Product
Table 151. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 152. BioCer Entwicklungs-GmbH. Sales Proportion of Hemostats by Product in 2024
Table 153. BioCer Entwicklungs-GmbH. Sales Proportion of Hemostats by Application in 2024
Table 154. BioCer Entwicklungs-GmbH. Sales Proportion of Hemostats by Geographic Area in 2024
Table 155. BioCer Entwicklungs-GmbH. Recent Developments
Table 156. Biom'Up SAS Company Information
Table 157. Biom'Up SAS Description and Business Overview
Table 158. Biom'Up SAS Hemostats Product
Table 159. Biom'Up SAS Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 160. Biom'Up SAS Sales Proportion of Hemostats by Product in 2024
Table 161. Biom'Up SAS Sales Proportion of Hemostats by Application in 2024
Table 162. Biom'Up SAS Sales Proportion of Hemostats by Geographic Area in 2024
Table 163. Biom'Up SAS Recent Developments
Table 164. North America Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 165. North America Hemostats Sales by Country (2026-2031) & (K Pcs)
Table 166. North America Hemostats Revenue by Country (2020-2025) & (US$ Million)
Table 167. North America Hemostats Revenue by Country (2026-2031) & (US$ Million)
Table 168. North America Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 169. North America Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 170. Asia-Pacific Hemostats Sales by Region (2020-2025) & (K Pcs)
Table 171. Asia-Pacific Hemostats Sales by Region (2026-2031) & (K Pcs)
Table 172. Asia-Pacific Hemostats Revenue by Region (2020-2025) & (US$ Million)
Table 173. Asia-Pacific Hemostats Revenue by Region (2026-2031) & (US$ Million)
Table 174. Asia-Pacific Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 175. Asia-Pacific Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 176. Europe Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 177. Europe Hemostats Sales by Country (2026-2031) & (K Pcs)
Table 178. Europe Hemostats Revenue by Country (2020-2025) & (US$ Million)
Table 179. Europe Hemostats Revenue by Country (2026-2031) & (US$ Million)
Table 180. Europe Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 181. Europe Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 182. Latin America Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 183. Latin America Hemostats Sales by Country (2026-2031) & (K Pcs)
Table 184. Latin America Hemostats Revenue by Country (2020-2025) & (US$ Million)
Table 185. Latin America Hemostats Revenue by Country (2026-2031) & (US$ Million)
Table 186. Latin America Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 187. Latin America Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 188. Middle East and Africa Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 189. Middle East and Africa Hemostats Sales by Country (2026-2031) & (K Pcs)
Table 190. Middle East and Africa Hemostats Revenue by Country (2020-2025) & (US$ Million)
Table 191. Middle East and Africa Hemostats Revenue by Country (2026-2031) & (US$ Million)
Table 192. Middle East and Africa Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 193. Middle East and Africa Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 194. Hemostats Key Raw Materials, Industry Status and Trend
Table 195. Hemostats Key Raw Materials and Upstream Suppliers
Table 196. Hemostats Clients Status and Trend
Table 197. Hemostats Typical Clients
Table 198. Hemostats Distributors
Table 199. Hemostats Market Trends
Table 200. Hemostats Market Drivers
Table 201. Hemostats Market Challenges
Table 202. Hemostats Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hemostats Product Picture
Figure 2. Global Hemostats Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Hemostats Sales Market Share by Type in 2024 & 2031
Figure 4. Thrombin-Based Hemostats Product Picture
Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 6. Combination Hemostats Product Picture
Figure 7. Gelatin Based Hemostats Product Picture
Figure 8. Collagen Based Hemostats Product Picture
Figure 9. Global Hemostats Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global Hemostats Sales Market Share by Application in 2024 & 2031
Figure 11. Prehospital Treatment
Figure 12. Hospital Treatment
Figure 13. Hemostats Report Years Considered
Figure 14. Global Hemostats Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Hemostats Market Size 2020-2031 (US$ Million)
Figure 16. Global Hemostats Sales 2020-2031 (K Pcs)
Figure 17. Global Hemostats Sales Market Share Forecast by Region (2020-2031)
Figure 18. Global Hemostats Revenue Market Share by Region (2020-2031)
Figure 19. Global Hemostats Sales Market Share Forecast by Type (2020-2031)
Figure 20. Global Hemostats Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Hemostats Average Selling Price (ASP) by Type (2020-2025) & (USD/Pcs)
Figure 22. Global Hemostats Sales Market Share Forecast by Application (2020-2031)
Figure 23. Global Hemostats Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Hemostats Average Selling Price (ASP) by Application (2020-2025) & (USD/Pcs)
Figure 25. Thrombin-Based Hemostats of Hemostats Revenue Market Share by Application, 2024 VS 2031
Figure 26. Oxidized Regenerated Cellulose Based Hemostats of Hemostats Revenue Market Share by Application, 2024 VS 2031
Figure 27. Combination Hemostats of Hemostats Revenue Market Share by Application, 2024 VS 2031
Figure 28. Gelatin Based Hemostats of Hemostats Revenue Market Share by Application, 2024 VS 2031
Figure 29. Collagen Based Hemostats of Hemostats Revenue Market Share by Application, 2024 VS 2031
Figure 30. Global Hemostats Sales Share by Manufacturer in 2024
Figure 31. Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. Thrombin-Based Hemostats Market Sales Proportion by Manufacturer in 2024
Figure 33. Oxidized Regenerated Cellulose Based Hemostats Market Sales Proportion by Manufacturer in 2024
Figure 34. Combination Hemostats Market Sales Proportion by Manufacturer in 2024
Figure 35. Gelatin Based Hemostats Market Sales Proportion by Manufacturer in 2024
Figure 36. Collagen Based Hemostats Market Sales Proportion by Manufacturer in 2024
Figure 37. North America Hemostats Revenue 2020-2031 (US$ Million)
Figure 38. North America Hemostats Sales Market Share by Type (2020-2025)
Figure 39. North America Hemostats Sales Market Share by Application (2020-2025)
Figure 40. Asia-Pacific Hemostats Revenue 2020-2031 (US$ Million)
Figure 41. Asia-Pacific Hemostats Sales Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Hemostats Revenue Market Share by Region (2020-2031)
Figure 43. Asia-Pacific Hemostats Sales Market Share by Type (2020-2025)
Figure 44. Asia-Pacific Hemostats Sales Market Share by Application (2020-2025)
Figure 45. Europe Hemostats Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Europe Hemostats Sales Market Share by Country (2020-2031)
Figure 47. Europe Hemostats Revenue Market Share by Country (2020-2031)
Figure 48. Europe Hemostats Sales Market Share by Type (2020-2025)
Figure 49. Europe Hemostats Sales Market Share by Application (2020-2025)
Figure 50. Latin America Hemostats Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Latin America Hemostats Sales Market Share by Country (2020-2031)
Figure 52. Latin America Hemostats Revenue Market Share by Country (2020-2025)
Figure 53. Latin America Hemostats Sales Market Share by Type (2020-2025)
Figure 54. Latin America Hemostats Sales Market Share by Application (2020-2025)
Figure 55. Middle East and Africa Hemostats Revenue Growth Rate 2020-2031 (US$ Million)
Figure 56. Middle East and Africa Hemostats Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Hemostats Revenue Market Share by Country (2020-2031)
Figure 58. Middle East and Africa Hemostats Sales Market Share by Type (2020-2025)
Figure 59. Middle East and Africa Hemostats Sales Market Share by Application (2020-2025)
Figure 60. Hemostats Supply Chain (Upstream and Downstream Market)
Figure 61. Global Production Market Share of Hemostats Raw Materials by Region in 2024
Figure 62. Hemostats Distribution Channels
Figure 63. Global Hemostats Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 64. Global Hemostats Percentage 2020-2031: Online Sales VS Offline Sales
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Hemostats market size from 2025 to 2031?
The annual compound growth rate of the global Hemostats market is 5.9% 2025 to 2031.
Which companies rank high in the global Hemostats market?
What was the global market size of Hemostats in 2025?
Which region is expected to have the highest market share?
What was the global market size of Hemostats in 2031?
Related Reports
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-08
Pages: 175
USD 4900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-08
Pages: 104
USD 4250.00
(Single User License)
Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 134
USD 2900.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 143
USD 3950.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 173
USD 4900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 106
USD 4250.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 150
USD 3950.00
(Single User License)
Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 106
USD 2900.00
(Single User License)
Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-17
Pages: 182
USD 5600.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-16
Pages: 160
USD 5900.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-08
Pages: 175
USD 4900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 104
USD 4250.00 (Single User License)Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 134
USD 2900.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 143
USD 3950.00 (Single User License)Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 173
USD 4900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 106
USD 4250.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 150
USD 3950.00 (Single User License)Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 106
USD 2900.00 (Single User License)Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-17
Pages: 182
USD 5600.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-16
Pages: 160
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now